<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02524756</url>
  </required_header>
  <id_info>
    <org_study_id>LNS-RH</org_study_id>
    <nct_id>NCT02524756</nct_id>
  </id_info>
  <brief_title>Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy</brief_title>
  <official_title>Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Osama Mohammad Ali ElDamshety</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess:

        1. Evaluation of the feasibility of laparoscopic nerve sparing radical hysterectomy type
           III/C1 as regard surgical technique, blood loss and operative time.

        2. Evaluate patients' outcome as regard bladder function.

      in order to preserve the function of the bladder and the rectum, it is necessary to modify
      the traditional procedures, so as to identify the precise anatomical information directing
      the technique for optimal preservation of bladder function at the time of radical
      hysterectomy.

      The laparoscopic technique offers several well-known advantages. Under the magnified view of
      the laparoscope, the anatomy can be clearly visualized to allow for the meticulous and
      precise dissection of the para-cervical structures and areolar tissue, including the blood
      vessels and the nerves.

      Laparoscopic identification (neurolysis) of the inferior hypogastric nerve and inferior
      hypogastric plexus is a feasible procedure for trained laparoscopic surgeons who have a good
      knowledge not only of the retroperitoneal anatomy but also of the pelvic neuro-anatomy as
      this qualification could prohibit long-term bladder and voiding dysfunction during
      nerve-sparing radical hysterectomy
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2014</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional outcome of laparoscopic nerve sparing radical hysterectomy type III/C1</measure>
    <time_frame>1 month</time_frame>
    <description>Duration of postoperative catheterization untill PVR urine volume is less than 100 ml</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative complications</measure>
    <time_frame>During Surgery</time_frame>
    <description>intraoperative complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>Day of surgery</time_frame>
    <description>Amount of blood intraoperative blood loss in ml. units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>Day of surgery</time_frame>
    <description>Minutes for the surgical intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early postoperative complication</measure>
    <time_frame>30 days</time_frame>
    <description>Occurence of early postoperative complication within 30 days of operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late postoperative complication</measure>
    <time_frame>more than 30 days postoperative</time_frame>
    <description>complications related to surgery more than 30 days postoperative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bladder training exercise</measure>
    <time_frame>1 month</time_frame>
    <description>Removal of urinary catheter on the 3rd day postoperative without prior bladder training exercise and measurement of PVR urine volume</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Cervical Cancer</condition>
  <arm_group>
    <arm_group_label>Group (A)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>laparoscopic nerve sparing radical hysterectomy type III/C1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group (B)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>laparoscopic radical hysterectomy type III/C2</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic nerve-sparing radical hysterectomy-type III/C1</intervention_name>
    <arm_group_label>Group (A)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic radical hysterectomy (type III/C2).</intervention_name>
    <arm_group_label>Group (B)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 18 years.

          2. Karnofsky &gt; 80, or American Society of anaethesiology (ASA) I-II

          3. Stage IA2-IB1-IB2-IIA1-IIA2-IIB cervical cancer according to FIGO (International
             Federation of Gynecology and Obstetrics) staging.

          4. Stage II, III endometrial cancer

        Exclusion Criteria:

          1. Non Invasive Cancer

          2. Pregnancy

          3. Bladder dysfunction detected prior to surgery.

          4. Previous pelvic lymphadenectomy.

          5. Tumour recurrence

          6. Incomplete surgery, unresectable lesion.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khaled Gaballa, MS.c.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Lecturer of surgical oncology, Mansoura universitry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adel Taha Denewar, M.D., Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Head of surgical oncology department, Mansoura oncology centre, Mansoura university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giovanni Scambia, M.D.,Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Head of the Department for Woman and Unborn Life Health Care- Catholic University of the Sacred Heart- Rome, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valerio Gallotta, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Department of Gynecologic Oncology,Catholic University of the Sacred Heart,Rome,Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Mansourah</city>
        <state>Dakahlia</state>
        <zip>35511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Largo Agostino Gemelli</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2015</study_first_submitted>
  <study_first_submitted_qc>August 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2015</study_first_posted>
  <last_update_submitted>March 2, 2018</last_update_submitted>
  <last_update_submitted_qc>March 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Osama Mohammad Ali ElDamshety</investigator_full_name>
    <investigator_title>surgical oncology</investigator_title>
  </responsible_party>
  <keyword>nerve sparing radical hysterectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

